BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25347096)

  • 21. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
    Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
    J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of Lysine-Specific Demethylase 1 Is Associated With Tumor Progression and Unfavorable Prognosis in Chinese Patients With Endometrioid Endometrial Adenocarcinoma.
    Liu YD; Dai M; Yang SS; Xiao M; Meng FL; Chen XW
    Int J Gynecol Cancer; 2015 Oct; 25(8):1453-60. PubMed ID: 26166558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
    Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of focal adhesion kinase in patients with endometrial cancer: a clinicopathologic study.
    Gabriel B; Hasenburg A; Waizenegger M; Orlowska-Volk M; Stickeler E; zur Hausen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1221-5. PubMed ID: 19823058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value.
    Srdelić Mihalj S; Kuzmić-Prusac I; Zekić-Tomaš S; Šamija-Projić I; Čapkun V
    Histopathology; 2015 Aug; 67(2):206-15. PubMed ID: 25522256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
    Shang P; Meng F; Liu Y; Chen X
    Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of stromal versican expression in human endometrial cancer.
    Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
    Ann Oncol; 2007 Feb; 18(2):269-74. PubMed ID: 17065588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival analysis of endometrial cancer patients with positive lymph nodes.
    Brown AP; Gaffney DK; Dodson MK; Soisson AP; Belnap TW; Alleman K; Sause WT
    Int J Gynecol Cancer; 2013 Jun; 23(5):861-8. PubMed ID: 23598890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer.
    Mansour MA; Hyodo T; Akter KA; Kokuryo T; Uehara K; Nagino M; Senga T
    Oncotarget; 2016 Jan; 7(4):4993-5006. PubMed ID: 26701851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
    Nakazawa T; Goi T; Hirono Y; Yamaguchi A
    Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunolocalization of corticotropin-releasing hormone (CRH) and its receptors (CRHR1 and CRHR2) in human endometrial carcinoma: CRHR1 as a potent prognostic factor.
    Sato N; Takagi K; Suzuki T; Miki Y; Tanaka S; Nagase S; Warita H; Fukudo S; Sato F; Sasano H; Ito K
    Int J Gynecol Cancer; 2014 Nov; 24(9):1549-57. PubMed ID: 25254562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
    Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
    Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
    Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
    Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SATB1 Expression of Colorectal Adenomatous Polyps is Higher than that of Colorectal Carcinomas.
    Yalcin GS; Gonultas MA; Hucumenoglu S; Simsek G; Pekcici MR
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):532-537. PubMed ID: 31290787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
    dos Reis R; Burzawa JK; Tsunoda AT; Hosaka M; Frumovitz M; Westin SN; Munsell MF; Ramirez PT
    Int J Gynecol Cancer; 2015 Sep; 25(7):1292-9. PubMed ID: 26067863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer.
    Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y
    Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
    Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
    Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.